Clinical Trials

Hemophilia

Displaying 5 studies

A Study of Previously Untreated Patients (PUPs) with Congenital Hemophilia Rochester, MN

The purpose of this study is to determine the percentage of subjects with confirmed inhibitors (per CDC laboratory criteria; >0.5 Nijmegen Bethesda Units for hemophilia A and >0.3 Nijmegen Bethesda Units for hemophilia B within the first 50 Exposure Days (ED).
A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B Rochester, MN

This trial is conducted in Europe and the United States of America. The aim of this trial is to compare the pharmacokinetics (the exposure of the trial drug in the body) of nonacog beta pegol (N9-GP) and ALPROLIX® in patients with haemophilia B.
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors Rochester, MN

The purpose of this study is to evaluate the safety of SEVENFACT® when used to treat bleeding events in participants with Hemophilia A or B with inhibitors either with or without prophylactic treatment.
A Study of the Health Issues of Bleeding Disorders Rochester, MN

The purpose of this study is to monitor and better understand the health issues of people with bleeding disorders.
ATHN 11: A Study of Liver Transplantation Outcomes Rochester, MN

The purpose of this study is to observe participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.